Resyca® Soft Nasal Spray Adaptor: low shear forces and optimal nasal coverage

Resyca® PFSI™ Soft Mist Inhaler (SMI): Inhalation spray in a convenient device

Soft mist inhaler nebulisation by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols

Evaluation of Rayleigh jet atomiser for intranasal delivery of lipid nanoparticle – siRNA formulations: stability, deposition, and device performance

Rayleigh-based soft mist inhalers preserve mRNA-LNP integrity for pulmonary delivery

Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technology

A device screening method for predicting delivery of inhaled mRNA via a nebuliser

Assessing the variability of in silico lung deposition predictions when inhaling from soft mist inhalers with various air flow resistances

Improved olfactory deposition of theophylline using a nanotech soft mist nozzle chip

Influence of fluid physiochemical properties on aerosolisation performance of a novel soft mist inhaler

Usability and inspiratory flow profiles of patients with pulmonary hypertension inhaling with a novel Soft Mist Inhaler (SMI)

Advances in soft mist inhalers

Successful phase 2/3 study with Heparin delivered with Pulmospray

Degradation of lipid based drug delivery formulations during nebulisation

Inhalation delivery of complex drugs – the next steps